skip to content
Novel designs of early phase trials for cancer therapeutics Preview this item
ClosePreview this item
Checking...

Novel designs of early phase trials for cancer therapeutics

Author: Shivaani Kummar; Chris Takimoto
Publisher: London, United Kingdom : Academic Press, an imprint of Elsevier, 2018.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Novel designs of early phase trials for cancer therapeutics.
London, United Kingdom : Academic Press, an imprint of Elsevier, 2018
(OCoLC)1011518186
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Shivaani Kummar; Chris Takimoto
ISBN: 9780128125700 0128125705
OCLC Number: 1037946027
Notes: Includes index.
Description: 1 online resource
Contents: Front Cover; Novel Designs of Early Phase Trials for Cancer Therapeutics; Copyright Page; Dedication; Contents; List of Contributors; Preface; 1 Changing Landscape of Early Phase Clinical Trials: Beyond the Horizon; 1.1 Historical Perspective; 1.2 Current Trends; References; 2 Requirements for Filing an Investigational New Drug Application; 2.1 Exemptions to Filing an IND; 2.2 Types of IND Applications; 2.3 Regulatory and Administrative Components of an IND Application; 2.4 FDA IND Review; 2.5 IND Reporting Requirements; 2.5.1 Expedited Safety Reporting; 2.5.2 Annual Reporting 2.6 FDA Meetings2.7 IND Applications for Combination Therapies; 2.8 Applications for Companion Diagnostic Devices; 3 The Evolution of Phase I Trials, Past, Present, and Future: A Biostatistical Perspective; 3.1 Traditional Dose Finding: Toxicity-Based Designs; 3.1.1 Common Trial Designs for Toxicity-Based Dose Finding of Single Agents; 3.1.2 Toxicity-Based Dose-Finding Designs for Combinations; 3.1.3 Other Toxicity-Based Dose-Finding Designs; 3.1.4 (Re)defining Toxicity Endpoints; 3.2 Efficacy and Toxicity-Based Dose-Finding Designs; 3.3 Expansion Cohorts and Phase I/II Trials 3.4 Recent Trends in Phase I Trial Designs3.4.1 Breakthrough Therapy Designation and Its Impact on Trial Designs; 3.4.2 Statistical Challenges in Dose Finding Based in the Era of Immunotherapies and Targeted Agents; 3.5 Where Do We Go From Here: Recommendations for Optimal Early Phase Dose-Finding Trials; 3.5.1 Windows of Time for Evaluation of Toxicities; 3.5.2 Intrapatient Dose Escalation; 3.5.3 Delayed Clinical Responses, "Pseudo-Progression," and Duration of Response; 3.5.4 Measures of Efficacy for Dose Finding: Clinical Versus Correlative Outcomes; 3.5.5 Sample Size and Cohort Selection 3.5.6 Using Expansion Cohorts to Recalibrate Dose3.5.7 Abandon the Terms "Phase I, II, and III"; 3.6 Summary; References; 4 Evolving Early Phase Trial Designs: A Regulatory Perspective; 4.1 Introduction; 4.2 FDA Expedited Programs for Expediting the Development and Review of Drugs for Serious or Life-Threatening Conditions; 4.2.1 Fast Track Development Program Designation; 4.2.2 Breakthrough Therapy Development Program Designation; 4.2.3 Priority Review Designation of a New Drug Application/Biologics License Application; 4.2.4 Accelerated Approval and Regular Approval 4.3 Multiarm Expansion Cohorts in Early Phase Trials4.3.1 Traditional Drug Development Paradigm and Seamless Oncology Expansion Cohort Drug Development Paradigm; 4.3.2 Examples of Expansion Cohorts in Seamless Oncology Trials; 4.3.3 Regulatory Considerations of Seamless Oncology Expansion Cohort FIH Trials-Opportunities and Challenges; 4.3.3.1 Safety Considerations; 4.3.3.2 Efficacy Considerations; 4.4 Summary; References; 5 The Challenges of Implementing Multiarmed Early Phase Oncology Clinical Trials; 5.1 Introduction; 5.2 Evolution of Early Phase Clinical Trials; 5.2.1 Endpoints
Responsibility: edited by Shivaani Kummar, Chris Takimoto.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1037946027> # Novel designs of early phase trials for cancer therapeutics
    a schema:MediaObject, schema:Book, schema:CreativeWork ;
    library:oclcnum "1037946027" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/enk> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/5191664632#Topic/medical_pharmacology> ; # MEDICAL--Pharmacology
    schema:about <http://experiment.worldcat.org/entity/work/data/5191664632#Topic/antineoplastic_agents_pharmacology> ; # Antineoplastic Agents--pharmacology
    schema:about <http://dewey.info/class/615.798/e23/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/5191664632#Topic/drug_development> ; # Drug development
    schema:about <http://experiment.worldcat.org/entity/work/data/5191664632#Topic/antineoplastic_agents_testing> ; # Antineoplastic agents--Testing
    schema:about <http://experiment.worldcat.org/entity/work/data/5191664632#Topic/antineoplastic_agents_therapeutic_use> ; # Antineoplastic Agents--therapeutic use
    schema:bookFormat schema:EBook ;
    schema:datePublished "2018" ;
    schema:description "Front Cover; Novel Designs of Early Phase Trials for Cancer Therapeutics; Copyright Page; Dedication; Contents; List of Contributors; Preface; 1 Changing Landscape of Early Phase Clinical Trials: Beyond the Horizon; 1.1 Historical Perspective; 1.2 Current Trends; References; 2 Requirements for Filing an Investigational New Drug Application; 2.1 Exemptions to Filing an IND; 2.2 Types of IND Applications; 2.3 Regulatory and Administrative Components of an IND Application; 2.4 FDA IND Review; 2.5 IND Reporting Requirements; 2.5.1 Expedited Safety Reporting; 2.5.2 Annual Reporting"@en ;
    schema:editor <http://experiment.worldcat.org/entity/work/data/5191664632#Person/kummar_shivaani> ; # Shivaani Kummar
    schema:editor <http://experiment.worldcat.org/entity/work/data/5191664632#Person/takimoto_chris> ; # Chris Takimoto
    schema:exampleOfWork <http://worldcat.org/entity/work/id/5191664632> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1011518186> ;
    schema:name "Novel designs of early phase trials for cancer therapeutics"@en ;
    schema:productID "1037946027" ;
    schema:url <http://0-www.sciencedirect.com.pugwash.lib.warwick.ac.uk/science/book/9780128125120> ;
    schema:url <https://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=5402112> ;
    schema:url <https://nls.ldls.org.uk/welcome.html?ark:/81055/vdc_100059303455.0x000001> ;
    schema:url <https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1649236> ;
    schema:url <https://www.sciencedirect.com/science/book/9780128125120> ;
    schema:workExample <http://worldcat.org/isbn/9780128125700> ;
    umbel:isLike <http://bnb.data.bl.uk/id/resource/GBB8A5150> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1037946027> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/5191664632#Person/kummar_shivaani> # Shivaani Kummar
    a schema:Person ;
    schema:familyName "Kummar" ;
    schema:givenName "Shivaani" ;
    schema:name "Shivaani Kummar" ;
    .

<http://experiment.worldcat.org/entity/work/data/5191664632#Person/takimoto_chris> # Chris Takimoto
    a schema:Person ;
    schema:familyName "Takimoto" ;
    schema:givenName "Chris" ;
    schema:name "Chris Takimoto" ;
    .

<http://experiment.worldcat.org/entity/work/data/5191664632#Topic/antineoplastic_agents_pharmacology> # Antineoplastic Agents--pharmacology
    a schema:Intangible ;
    schema:name "Antineoplastic Agents--pharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/5191664632#Topic/antineoplastic_agents_testing> # Antineoplastic agents--Testing
    a schema:Intangible ;
    schema:name "Antineoplastic agents--Testing"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/5191664632#Topic/antineoplastic_agents_therapeutic_use> # Antineoplastic Agents--therapeutic use
    a schema:Intangible ;
    schema:name "Antineoplastic Agents--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/5191664632#Topic/medical_pharmacology> # MEDICAL--Pharmacology
    a schema:Intangible ;
    schema:name "MEDICAL--Pharmacology"@en ;
    .

<http://worldcat.org/isbn/9780128125700>
    a schema:ProductModel ;
    schema:isbn "0128125705" ;
    schema:isbn "9780128125700" ;
    .

<http://www.worldcat.org/oclc/1011518186>
    a schema:CreativeWork ;
    rdfs:label "Novel designs of early phase trials for cancer therapeutics." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1037946027> ; # Novel designs of early phase trials for cancer therapeutics
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.